Cecile Bauche
Company: Alaya Bio
Job title: Chief Scientific Officer
Seminars:
From NEXT to NICE: From Nanoparticles-based Ex vivo Therapeutics to Nanoparticles-based In vivo Cell Engineering 3:30 pm
• Hybrid/polymeric nanoparticles as a solution to improve CAR T-cell manufacturing process and CAR T-cell product attributes. • Key performance criteria for an ideal in vivo CAR re-infusable product • Translational hurdles from ex vivo to in vivo CARsRead more
day: Day 1